Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gretchen Vanraalte"'
Autor:
Richard J.R. Johnson, Gretchen Vanraalte, Todd H. Wasserman, Theodore L. Phillips, Victor A. Levin
Publikováno v:
Cancer. 48:1697-1704
The hypoxic cell sensitizer misonidazole began phase I evaluation in the United States in July 1977. One hundred two patients received 104 individual courses of drug. Drug was administered from once to five times per week over time spans from one to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02433ce6e786a5c153a3dc9edcb70f46
https://doi.org/10.1002/1097-0142(19811015)48:8<1697::aid-cncr2820480802>3.0.co
https://doi.org/10.1002/1097-0142(19811015)48:8<1697::aid-cncr2820480802>3.0.co
Autor:
Gretchen Vanraalte, Todd H. Wasserman, Charles J. Gomer, Roberto A. Marques, Richard J.R. Johnson, Victor A. Levin, Gilbert Lawrence, Theodore L. Phillips, Wolfgang Sadee
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 5:775-786
The hypoxic cell radiosensitizer, misonidazole, is in a Phase I clinical pharmacology and toxicology trial. Forty patients were evaluated on a weekly dose schedule. Misonidazole was given on the dose schedule of a single oral dose weekly for 3 or 6 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57aeb6dfd37ab3ac8fa018af64fa6646
https://doi.org/10.1016/0360-3016(79)90061-0
https://doi.org/10.1016/0360-3016(79)90061-0
Publikováno v:
International journal of radiation oncology, biology, physics. 8(2)
A total of 34 patients were studied in order to evaluate capsule vs. tablet form of misonidazole and intermittent vs. daily administration. These patients were given drug formulation of tablets for one week and capsules for one week on either an inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559dd32caf9199764ab7f4b07c650e5e
https://pubmed.ncbi.nlm.nih.gov/7085383
https://pubmed.ncbi.nlm.nih.gov/7085383
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 6:1388-1389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f69b518bb9eeb0acd7c2e159a9df1fd
https://doi.org/10.1016/0360-3016(80)90486-1
https://doi.org/10.1016/0360-3016(80)90486-1
Autor:
Victor A. Levin, Wolfgang Sadee, Richard J.R. Johnson, Gretchen Vanraalte, Gilbert Lawrence, Theodore L. Phillips, Todd H. Wasserman, Charles J. Gomer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 4:132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc3e15b4cc1b16fa5ca4760ebd72fc3a
https://doi.org/10.1016/0360-3016(78)90306-1
https://doi.org/10.1016/0360-3016(78)90306-1
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 10:1812
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d84b42134785f47fb48d2eee9dbef7
https://doi.org/10.1016/0360-3016(84)90591-1
https://doi.org/10.1016/0360-3016(84)90591-1